Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia

Clinical trial NCT02402998 · COMPLETED

Trial details

NCT number: NCT02402998
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primacy Immune Thrombocytopenia

Start date: 2016-02-24
Primary completion: 2018-05-22
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.